or Try an Advanced Search...

    Treatment Of Parkinson's Disease Stocks List

    Symbol Grade Name % Change
    ACAD D ACADIA Pharmaceuticals Inc. 2.03
    ATHE C Alterity Therapeutics Limited 5.01
    AMRX A Amneal Pharmaceuticals, Inc. 1.07
    CCM B Concord Medical Services Holdings Limited ADS -10.20
    IKT F Inhibikase Therapeutics, Inc. -8.16
    ITCI B Intra-Cellular Therapies Inc. 1.28
    NERV F Minerva Neurosciences, Inc 1.70
    NRSNW D NeuroSense Therapeutics Ltd. - warrant 13.99
    TEVA B Teva Pharmaceutical Industries -0.50
    VYGR C Voyager Therapeutics, Inc. 6.91
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Care
    Related Stock Lists: Parkinson's Disease Alzheimer's Disease Medicine Drugs Neuroscience Schizophrenia Aging Associated Diseases Amyotrophic Lateral Sclerosis Biopharmaceutical Biotechnology Cancer Dementia Depressive Disorder Huntington's Disease Insomnia Major Depressive Disorder Medication Neurological Disorders Pain Pharmaceutical

    Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Parkinson's Disease stocks.

    Symbol Grade Name Weight
    IBRN C iShares Neuroscience and Healthcare ETF 8.93
    ISRA C Market Vectors Israel ETF 8.54
    EIS C iShares MSCI Israel Capped Investable Market Index Fund 7.7
    FBT D First Trust Amex Biotech Index Fund 7.05
    XPH D SPDR S&P Pharmaceuticals ETF 6.17
    View all Treatment Of Parkinson's Disease ETFs...
    Compare ETFs
    Compare FBT to XPH Compare IBRN to XPH Compare ISRA to XPH

        Treatment Of Parkinson's Disease Stocks Recent News

        Date Stock Title
        May 1 ITCI Acadia Pharmaceuticals (ACAD) Earnings Expected to Grow: Should You Buy?
        May 1 NERV Minerva Neurosciences GAAP EPS of -$1.13
        May 1 NERV Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business Updates
        Apr 30 TEVA Novo, Teva, AstraZeneca issued FTC warnings over ‘bogus’ patents
        Apr 30 ITCI Intra-Cellular Therapies to Host First Quarter 2024 Financial Results Conference Call and Webcast
        Apr 30 ITCI Intra-Cellular Therapies: Positive MDD Data And Commercial Momentum Make It A Buy
        Apr 30 TEVA U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® (adalimumab)
        Apr 29 ACAD Acadia Pharmaceuticals is Proud to Announce the Winners of the Inaugural Rett Sibling Scholarship
        Apr 28 ACAD ACADIA Pharmaceuticals (NASDAQ:ACAD) shareholders have endured a 37% loss from investing in the stock five years ago
        Apr 26 CCM Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
        Apr 25 ITCI Will Intra-Cellular Therapies (ITCI) Report Negative Q1 Earnings? What You Should Know
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Care
        Related Stock Lists: Parkinson's Disease Alzheimer's Disease Medicine Drugs Neuroscience Schizophrenia Aging Associated Diseases Amyotrophic Lateral Sclerosis Biopharmaceutical Biotechnology Cancer Dementia Depressive Disorder Huntington's Disease Insomnia Major Depressive Disorder Medication Neurological Disorders Pain Pharmaceutical
        Treatment Of Parkinson's Disease

        Treatment of Parkinson's disease typically involves a combination of medications, lifestyle changes, and therapies. Medications used to treat Parkinson's disease include levodopa, dopamine agonists, MAO-B inhibitors, anticholinergics, and amantadine. Lifestyle changes may include exercise, diet, and stress management. Therapies such as physical therapy, occupational therapy, speech therapy, and cognitive behavioral therapy may also be used to help manage symptoms.

        Browse All Tags